 | • レポートコード：GIR-22F19831 • 出版社/出版日：GlobalInfoResearch / 2022年11月 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（2~3営業日） • 産業分類：化学＆材料 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「Global Medicinal Radiocompounds Market 2022」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 グローバルインフォリサーチ社の最新の調査によると、世界の医療用放射性化合物の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 医療用放射性化合物市場はタイプ（種類）とアプリケーション（用途）によって区分されます。2017年～2028年において、量と金額の観点からタイプ別およびアプリケーション別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 タイプ別セグメントは次をカバーします。 ・テクネチウム99、フッ素18、その他 アプリケーション別セグメントは次のように区分されます。 ・がん、循環器、その他 世界の医療用放射性化合物市場の主要な市場プレーヤーは以下のとおりです。 ・Bracco Imaging、Bayer、Cardinal Health、Curium Pharma、Novartis、Lantheus、Acrotech Biopharma、GE Healthcare、China Isotope & Radiation、Jubilant Pharma、Eli Lilly、SIEMENS、Dongcheng 地域別セグメントは次の地域・国をカバーします。 ・北米市場（米国、カナダ、メキシコ） ・ヨーロッパ市場（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋市場（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南米市場（ブラジル、アルゼンチン、コロンビア） ・中東・アフリカ市場（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、医療用放射性化合物製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な医療用放射性化合物メーカーの企業概要、2019年～2022年までの医療用放射性化合物の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な医療用放射性化合物メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別医療用放射性化合物の販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までの医療用放射性化合物のタイプ別とアプリケーション別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での医療用放射性化合物市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、および医療用放射性化合物の産業チェーンを掲載しています。 ・第13、14、15章では、医療用放射性化合物の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 - 医療用放射性化合物の概要 - タイプ別分析（2017年vs2021年vs2028年）：テクネチウム99、フッ素18、その他 - アプリケーション別分析（2017年vs2021年vs2028年）：がん、循環器、その他 - 世界の医療用放射性化合物市場規模・予測 - 世界の医療用放射性化合物生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Bracco Imaging、Bayer、Cardinal Health、Curium Pharma、Novartis、Lantheus、Acrotech Biopharma、GE Healthcare、China Isotope & Radiation、Jubilant Pharma、Eli Lilly、SIEMENS、Dongcheng ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・タイプ別分析2017年-2028年：テクネチウム99、フッ素18、その他 ・アプリケーション別分析2017年-2028年：がん、循環器、その他 ・医療用放射性化合物の北米市場分析 - 医療用放射性化合物の北米市場：タイプ別市場規模2017年-2028年 - 医療用放射性化合物の北米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・医療用放射性化合物のヨーロッパ市場分析 - ：医療用放射性化合物のヨーロッパ市場：タイプ別市場規模2017年-2028年 - ：医療用放射性化合物のヨーロッパ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・医療用放射性化合物のアジア太平洋市場分析 - 医療用放射性化合物のアジア太平洋市場：タイプ別市場規模2017年-2028年 - 医療用放射性化合物のアジア太平洋市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・医療用放射性化合物の南米市場分析 - 医療用放射性化合物の南米市場：タイプ別市場規模2017年-2028年 - 医療用放射性化合物の南米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・医療用放射性化合物の中東・アフリカ市場分析 - 医療用放射性化合物の中東・アフリカ市場：タイプ別市場規模2017年-2028年 - 医療用放射性化合物の中東・アフリカ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Medicinal Radiocompounds market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Medicinal Radiocompounds market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Oncology accounting for % of the Medicinal Radiocompounds global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Technetium 99 segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Medicinal Radiocompounds include Bracco Imaging, Bayer, Cardinal Health, Curium Pharma, and Novartis, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Medicinal Radiocompounds market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Technetium 99
Fluorine 18
Other
Market segment by Application can be divided into
Oncology
Cardiology
Others
The key market players for global Medicinal Radiocompounds market are listed below:
Bracco Imaging
Bayer
Cardinal Health
Curium Pharma
Novartis
Lantheus
Acrotech Biopharma
GE Healthcare
China Isotope & Radiation
Jubilant Pharma
Eli Lilly
SIEMENS
Dongcheng
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Medicinal Radiocompounds product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Medicinal Radiocompounds, with price, sales, revenue and global market share of Medicinal Radiocompounds from 2019 to 2022.
Chapter 3, the Medicinal Radiocompounds competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Medicinal Radiocompounds breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Medicinal Radiocompounds market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Medicinal Radiocompounds.
Chapter 13, 14, and 15, to describe Medicinal Radiocompounds sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Medicinal Radiocompounds Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Medicinal Radiocompounds Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Technetium 99
1.2.3 Fluorine 18
1.2.4 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Medicinal Radiocompounds Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Others
1.4 Global Medicinal Radiocompounds Market Size & Forecast
1.4.1 Global Medicinal Radiocompounds Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Medicinal Radiocompounds Sales in Volume (2017-2028)
1.4.3 Global Medicinal Radiocompounds Price (2017-2028)
1.5 Global Medicinal Radiocompounds Production Capacity Analysis
1.5.1 Global Medicinal Radiocompounds Total Production Capacity (2017-2028)
1.5.2 Global Medicinal Radiocompounds Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Medicinal Radiocompounds Market Drivers
1.6.2 Medicinal Radiocompounds Market Restraints
1.6.3 Medicinal Radiocompounds Trends Analysis
2 Manufacturers Profiles
2.1 Bracco Imaging
2.1.1 Bracco Imaging Details
2.1.2 Bracco Imaging Major Business
2.1.3 Bracco Imaging Medicinal Radiocompounds Product and Services
2.1.4 Bracco Imaging Medicinal Radiocompounds Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Bayer
2.2.1 Bayer Details
2.2.2 Bayer Major Business
2.2.3 Bayer Medicinal Radiocompounds Product and Services
2.2.4 Bayer Medicinal Radiocompounds Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Cardinal Health
2.3.1 Cardinal Health Details
2.3.2 Cardinal Health Major Business
2.3.3 Cardinal Health Medicinal Radiocompounds Product and Services
2.3.4 Cardinal Health Medicinal Radiocompounds Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Curium Pharma
2.4.1 Curium Pharma Details
2.4.2 Curium Pharma Major Business
2.4.3 Curium Pharma Medicinal Radiocompounds Product and Services
2.4.4 Curium Pharma Medicinal Radiocompounds Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Novartis
2.5.1 Novartis Details
2.5.2 Novartis Major Business
2.5.3 Novartis Medicinal Radiocompounds Product and Services
2.5.4 Novartis Medicinal Radiocompounds Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Lantheus
2.6.1 Lantheus Details
2.6.2 Lantheus Major Business
2.6.3 Lantheus Medicinal Radiocompounds Product and Services
2.6.4 Lantheus Medicinal Radiocompounds Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Acrotech Biopharma
2.7.1 Acrotech Biopharma Details
2.7.2 Acrotech Biopharma Major Business
2.7.3 Acrotech Biopharma Medicinal Radiocompounds Product and Services
2.7.4 Acrotech Biopharma Medicinal Radiocompounds Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 GE Healthcare
2.8.1 GE Healthcare Details
2.8.2 GE Healthcare Major Business
2.8.3 GE Healthcare Medicinal Radiocompounds Product and Services
2.8.4 GE Healthcare Medicinal Radiocompounds Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 China Isotope & Radiation
2.9.1 China Isotope & Radiation Details
2.9.2 China Isotope & Radiation Major Business
2.9.3 China Isotope & Radiation Medicinal Radiocompounds Product and Services
2.9.4 China Isotope & Radiation Medicinal Radiocompounds Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Jubilant Pharma
2.10.1 Jubilant Pharma Details
2.10.2 Jubilant Pharma Major Business
2.10.3 Jubilant Pharma Medicinal Radiocompounds Product and Services
2.10.4 Jubilant Pharma Medicinal Radiocompounds Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Eli Lilly
2.11.1 Eli Lilly Details
2.11.2 Eli Lilly Major Business
2.11.3 Eli Lilly Medicinal Radiocompounds Product and Services
2.11.4 Eli Lilly Medicinal Radiocompounds Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 SIEMENS
2.12.1 SIEMENS Details
2.12.2 SIEMENS Major Business
2.12.3 SIEMENS Medicinal Radiocompounds Product and Services
2.12.4 SIEMENS Medicinal Radiocompounds Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Dongcheng
2.13.1 Dongcheng Details
2.13.2 Dongcheng Major Business
2.13.3 Dongcheng Medicinal Radiocompounds Product and Services
2.13.4 Dongcheng Medicinal Radiocompounds Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Medicinal Radiocompounds Breakdown Data by Manufacturer
3.1 Global Medicinal Radiocompounds Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Medicinal Radiocompounds Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Medicinal Radiocompounds
3.4 Market Concentration Rate
3.4.1 Top 3 Medicinal Radiocompounds Manufacturer Market Share in 2021
3.4.2 Top 6 Medicinal Radiocompounds Manufacturer Market Share in 2021
3.5 Global Medicinal Radiocompounds Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Medicinal Radiocompounds Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Medicinal Radiocompounds Market Size by Region
4.1.1 Global Medicinal Radiocompounds Sales in Volume by Region (2017-2028)
4.1.2 Global Medicinal Radiocompounds Revenue by Region (2017-2028)
4.2 North America Medicinal Radiocompounds Revenue (2017-2028)
4.3 Europe Medicinal Radiocompounds Revenue (2017-2028)
4.4 Asia-Pacific Medicinal Radiocompounds Revenue (2017-2028)
4.5 South America Medicinal Radiocompounds Revenue (2017-2028)
4.6 Middle East and Africa Medicinal Radiocompounds Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Medicinal Radiocompounds Sales in Volume by Type (2017-2028)
5.2 Global Medicinal Radiocompounds Revenue by Type (2017-2028)
5.3 Global Medicinal Radiocompounds Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Medicinal Radiocompounds Sales in Volume by Application (2017-2028)
6.2 Global Medicinal Radiocompounds Revenue by Application (2017-2028)
6.3 Global Medicinal Radiocompounds Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Medicinal Radiocompounds Sales by Type (2017-2028)
7.2 North America Medicinal Radiocompounds Sales by Application (2017-2028)
7.3 North America Medicinal Radiocompounds Market Size by Country
7.3.1 North America Medicinal Radiocompounds Sales in Volume by Country (2017-2028)
7.3.2 North America Medicinal Radiocompounds Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Medicinal Radiocompounds Sales by Type (2017-2028)
8.2 Europe Medicinal Radiocompounds Sales by Application (2017-2028)
8.3 Europe Medicinal Radiocompounds Market Size by Country
8.3.1 Europe Medicinal Radiocompounds Sales in Volume by Country (2017-2028)
8.3.2 Europe Medicinal Radiocompounds Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Medicinal Radiocompounds Sales by Type (2017-2028)
9.2 Asia-Pacific Medicinal Radiocompounds Sales by Application (2017-2028)
9.3 Asia-Pacific Medicinal Radiocompounds Market Size by Region
9.3.1 Asia-Pacific Medicinal Radiocompounds Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Medicinal Radiocompounds Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Medicinal Radiocompounds Sales by Type (2017-2028)
10.2 South America Medicinal Radiocompounds Sales by Application (2017-2028)
10.3 South America Medicinal Radiocompounds Market Size by Country
10.3.1 South America Medicinal Radiocompounds Sales in Volume by Country (2017-2028)
10.3.2 South America Medicinal Radiocompounds Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Medicinal Radiocompounds Sales by Type (2017-2028)
11.2 Middle East & Africa Medicinal Radiocompounds Sales by Application (2017-2028)
11.3 Middle East & Africa Medicinal Radiocompounds Market Size by Country
11.3.1 Middle East & Africa Medicinal Radiocompounds Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Medicinal Radiocompounds Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Medicinal Radiocompounds and Key Manufacturers
12.2 Manufacturing Costs Percentage of Medicinal Radiocompounds
12.3 Medicinal Radiocompounds Production Process
12.4 Medicinal Radiocompounds Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Medicinal Radiocompounds Typical Distributors
13.3 Medicinal Radiocompounds Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer